Abstract
A genetic risk score (GRS) based on 29 single nucleotide polymorpysms (SNPs) associated with high blood pressure (BP) was prospectively associated with development of hypertension, stroke and cardiovascular events. The aim of the present study was to evaluate the impact of this GRS on the incidence of aortic disease, including aortic dissection (AD), rupture or surgery of a thoracic (TAA) or abdominal (AAA) aortic aneurysm. More than 25,000 people from the Swedish Malmo Diet and Cancer Study had information on at least 24 SNPs and were followed up for a median ≥ 18 years. The number of BP elevating alleles of each SNPs, weighted by their effect size in the discovery studies, was summed into a BP-GRS. In Cox regression models, adjusted for traditional cardiovascular risk factors including hypertension, we found significant associations of the BP-GRS, prospectively, with incident TAA (hazard ratio (HR) 1.64 (95% confidence interval (CI) 1.081–2.475 comparing the third vs. the first tertile; p = 0.020) but not with either AAA or aortic dissection. Calibration, discrimination and reclassification analyses show modest improvement in prediction using the BP-GRS in addition to the model which used only traditional risk factors. A GRS for hypertension associates with TAA suggesting a link between genetic determinants of BP and aortic disease. The effect size is small but the addition of more SNPs to the GRS might improve its discriminatory capability.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Erbel R, Aboyans V, Boileau C, Bossone E, Di Bartolomeo R, Eggebrecht H. et al. ESC guidelines on the diagnosis and treatment of aortic diseases [Internet]. Eur Heart J. 2014;35:2873–926.
Sampson UKA, Norman PE, Fowkes FGR, Aboyans V, Song Y, Harrell FE. et al. Estimation of global and regional incidence and prevalence of abdominal aortic aneurysms 1990 to 2010 [Internet]. Global Heart . 2014;9:159–70.
Sampson UKA, Norman PE, Fowkes FGR, Aboyans V, Song Y, Harrell FE. et al. Global and regional burden of aortic dissection and aneurysms: mortality trends in 21 world regions, 1990 to 2010. Global Heart . 2014;9:171–80.
Golledge J, Muller J, Daugherty A, Norman P. Abdominal aortic aneurysm: pathogenesis and implications for management. Arterioscler Thromb Vasc Biol. 2006;26:2605–13.
Moll FL, Powell JT, Fraedrich G, Verzini F, Haulon S, Waltham M. et al. Management of abdominal aortic aneurysms clinical practice guidelines of the european society for vascular surgery. Eur J Vasc Endovasc Surg. 2017;41:S1–58.
Tsai TT, Trimarchi S, Nienaber CA. Acute aortic dissection: perspectives from the International Registry of Acute Aortic Dissection (IRAD). Eur J Vasc Endovasc Surg. 2017;37:149–59.
Howard DPJ, Banerjee A, Fairhead JF, Perkins J, Silver LE, Rothwell PM. Population-based study of incidence and outcome of acute aortic dissection and premorbid risk factor control: 10-year results from the oxford vascular study. Circulation. 2017;127:2031–7.
Klompas M.Does this Patient have acute Thorac aortic dissection? JAMA. 2017;287:2262–72.
Hiratzka LF, Bakris GL, Beckman JA, Bersin RM, Carr VF, Casey DE. et al. ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease. J Am Coll Cardiol. 2010;55:e27–9.
Fava C, Burri P, Almgren P, Groop L, Hulthén UL, Melander O. Heritability of ambulatory and office blood pressure phenotypes in Swedish families. J Hypertens. 2004;22:1717–21.
Ehret GB, Munroe PB, Rice KM, Bochud M, Johnson AD, Chasman DI. et al. Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature. 2011;478:103–9.
Levy D, Ehret GB, Rice K, Verwoert GC, Launer LJ, Dehghan A. et al. Genome-wide association study of blood pressure and hypertension. Nat Genet. 2009;41:677–87.
Newton-Cheh C, Johnson T, Gateva V, Tobin MD, Bochud M, Coin L. et al. Genome-wide association study identifies eight loci associated with blood pressure. Nat Genet. 2009;41:666–76.
Padmanabhan S, Melander O, Johnson T, Di Blasio AM, Lee WK, Gentilini D, et al. Genome-wide association study of blood pressure extremes identifies variant near UMOD associated with hypertension. Schork NJ, editor. PLoS Genet. 2010;6:e1001177.
Surendran P, Drenos F, Young R, Warren H, Cook JP, Manning AK. et al. Trans-ancestry meta-analyses identify rare and common variants associated with blood pressure and hypertension. Nat Genet. 2016;48:1151–61.
Ehret GB, Ferreira T, Chasman DI, Jackson AU, Schmidt EM, Johnson T, et al. The genetics of blood pressure regulation and its target organs from association studies in 342,415 individuals. Nat Genet. 2016;48:1171–84.
Fava C, Sjogren M, Montagnana M, Danese E, Almgren P, Engstrom G. et al. Prediction of blood pressure changes over time and incidence of hypertension by a genetic risk score in Swedes. Hypertension. 2013;61:319–26.
Fava C, Sjögren M, Olsson S, Lövkvist H, Jood K, Engström G. et al. A genetic risk score for hypertension associates with the risk of ischemic stroke in a Swedish case-control study. Eur J Hum Genet. 2015;23:969–74.
Fava C, Ohlsson T, Sjogren M, Tagetti A, Almgren P, Engstrom G. et al. Cardiovascular consequences of a polygenetic component of blood pressure in an urban-based longitudinal study: the Malmo diet and cancer. J Hypertens. 2014;32:1424–8.
Landenhed M, Engstrom G, Gottsater A, Caulfield MP, Hedblad B, Newton-Cheh C. et al. Risk profiles for aortic dissection and ruptured or surgically treated aneurysms: a prospective cohort study. J Am Hear Assoc. 2015;4:e001513.
Smith JG, Platonov PG, Hedblad B, Engström G, Melander O. Atrial fibrillation in the Malmö Diet and Cancer study: a study of occurrence, risk factors and diagnostic validity. Eur J Epidemiol. 2010;25:95–102.
Fava C, Ohlsson T, Sjögren M, Tagetti A, Almgren P, Engström G, et al. Cardiovascular consequences of a polygenetic component of blood pressure in an urban-based longitudinal study: The Malmo Diet and Cancer. J Hypertens. 2014;32:1424–8.
Riboli E, Elmståhl S, Saracci R, Gullberg B, Lindgärde F. The Malmo Food Study: validity of two dietary assessment methods for measuring nutrient intake. Int J Epidemiol. 1997;26:161S–173.
Ehret GB. Genome-wide association studies: contribution of genomics to understanding blood pressure and essential hypertension. Curr Hypertens Rep. 2010;12:17–25.
Fava C, Sjögren M, Montagnana M, Danese E, Almgren P, Engström G. et al. Prediction of blood pressure changes over time and incidence of hypertension by a genetic risk score in Swedes. Hypertension. 2013;61:319–26.
Ludvigsson JF, Otterblad-Olausson P, Pettersson BU, Ekbom A. The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research. Eur J Epidemiol. 2009;24:659–67.
Ludvigsson JF, Andersson E, Ekbom A, Feychting M, Kim J-L, Reuterwall C, et al. External review and validation of the Swedish national inpatient register. BMC Public Health. 2011;11:450.
Johansson LA, Westerling R. Comparing Swedish hospital discharge records with death certificates: implications for mortality statistics. Int J Epidemiol. 2000;29:495–502.
Hosmer DW, Hosmer T, Le Cessie S, Lemeshow S. A comparison of goodness-of-fit tests for the logistic regression model. Stat Med. 1997;16:965–80.
Pencina MJ, D’Agostino RB, D’Agostino RB, Vasan RS. Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond. Stat Med. 2008;27:157–72.
Pencina MJ, D’Agostino RB, Steyerberg EW. Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers. Stat Med. 2011;30:11–21.
LeMaire SA, McDonald M-LN, Guo D-C, Russell L, Miller CC, Johnson RJ. et al. Genome-wide association study identifies a susceptibility locus for thoracic aortic aneurysms and aortic dissections spanning FBN1 at 15q21.1. Nat Genet. 2011;43:996–1000.
Iakoubova OA, Tong CH, Rowland CM, Luke MM, Garcia VE, Catanese JJ, et al. Genetic variants in FBN-1 and risk for thoracic aortic aneurysm and dissection. Kiechl S, editor. PLoS ONE. 2014;9:e91437.
Acknowledgements
We acknowledge the Knut and Alice Wallenberg Foundation for its economic support of the SWEGENE DNA extraction facility. Source of funding: This study was supported by grants from the European Research Council (StG-282255) Swedish Medical Research Council, the Swedish Heart and Lung Foundation, the Medical Faculty of Lund University, Malmo University Hospital, the Albert Påhlsson Research Foundation, the Crafoord Foundation, the Ernhold Lundstroms Research Foundation, the Region Skane, Hulda and Conrad Mossfelt Foundation, King Gustaf V and Queen Victoria Foundation, the Lennart Hansson Memorial Fund, the Cariverona Foundation. JGS was supported by the European Research Council, Swedish Heart-Lung Foundation, the Wallenberg Center for Molecular Medicine in Lund, the Swedish Research Council, the Crafoord Foundation, governmental funding of clinical research within the Swedish National Health Service, Skåne University Hospital in Lund, and the Scania county.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
About this article
Cite this article
Tagetti, A., Bonafini, S., Ohlsson, T. et al. A genetic risk score for hypertension is associated with risk of thoracic aortic aneurysm. J Hum Hypertens 33, 658–663 (2019). https://doi.org/10.1038/s41371-018-0159-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41371-018-0159-6